Cargando…

Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections remain unmanageable in some parts of the world. As with other RNA viruses, mutations in the SARS-CoV-2 gene have been continuously evolving. Recently, four variants have been identified, B.1.1.7, B.1.351, P.1 and CAL.20C. These...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spratt, Austin N., Kannan, Saathvik R., Woods, Lucas T., Weisman, Gary A., Quinn, Thomas P., Lorson, Christian L., Sönnerborg, Anders, Byrareddy, Siddappa N., Singh, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225291/ https://www.ncbi.nlm.nih.gov/pubmed/34188776 http://dx.doi.org/10.1016/j.csbj.2021.06.037

Ejemplares similares

Infectivity of SARS-CoV-2: there Is Something More than D614G?
por: Kannan, Saathvik R., et al.
Publicado: (2020)

Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
por: Kannan, Saathvik R., et al.
Publicado: (2022)

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
por: Kannan, Saathvik R., et al.
Publicado: (2021)

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
por: Kannan, Saathvik R., et al.
Publicado: (2022)

Continued Complexity of Mutations in Omicron Sublineages
por: Spratt, Austin N., et al.
Publicado: (2022)

Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak
por: Kannan, Saathvik R., et al.
Publicado: (2022)

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
por: Spratt, Austin N., et al.
Publicado: (2021)

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Immune landscape of female reproductive tract and HIV susceptibility
por: Byrareddy, Siddappa N.
Publicado: (2021)

Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States
por: Singu, Sravani, et al.
Publicado: (2020)

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
por: Byrareddy, Siddappa N., et al.
Publicado: (2020)

An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise
por: Ali, Haider, et al.
Publicado: (2021)

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
por: Husain, Amjad, et al.
Publicado: (2020)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
por: Rothan, Hussin A., et al.
Publicado: (2020)

Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node
por: Dave, Rajnish S., et al.
Publicado: (2018)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

IFN-I Independent Antiviral Immune Response to Vesicular Stomatitis Virus Challenge in Mouse Brain
por: Mishra, Anurag R., et al.
Publicado: (2020)

Role of MicroRNAs in Bone Pathology during Chikungunya Virus Infection
por: Roy, Enakshi, et al.
Publicado: (2020)

Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques
por: Alvarez, Xavier, et al.
Publicado: (2020)

Peptide Nanoarray Scaffold Vaccine for SARS-COV-2 and Its Variants of Concerns
por: Zagorski, Karen, et al.
Publicado: (2022)

The 2022 outbreak and the pathobiology of the monkeypox virus
por: Kumar, Narendra, et al.
Publicado: (2022)

Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges
por: Hanna, John, et al.
Publicado: (2021)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin and DC SIGN positive compartments that are accessible to neutralizing antibodies
por: Johnson, Erica L, et al.
Publicado: (2014)

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
por: Acharya, Arpan, et al.
Publicado: (2022)

Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle
por: Byrareddy, Siddappa N., et al.
Publicado: (2015)

Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy
por: Thurman, Michellie, et al.
Publicado: (2020)

Molecular Aspects of COVID-19 Differential Pathogenesis
por: Rothan, Hussin A., et al.
Publicado: (2020)

Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein
por: Siddappa, Nagadenahalli Byrareddy, et al.
Publicado: (2006)

Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4
por: Zandian, Mohamad, et al.
Publicado: (2022)

High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses
por: Dutta, Debashis, et al.
Publicado: (2018)

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
por: Leinen, Zach J., et al.
Publicado: (2023)

ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics
por: Malik, Johid Reza, et al.
Publicado: (2023)

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
por: Tiwari, Ritudhwaj, et al.
Publicado: (2020)

NF-κB Duplications in the Promoter-Variant HIV-1C LTR Impact Inflammation Without Altering Viral Replication in the Context of Simian Human Immunodeficiency Viruses and Opioid-Exposure
por: Dave, Rajnish S., et al.
Publicado: (2020)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

Catching BETs by viruses
por: Zandian, Mohamad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n960g1stdkvmadsgcvu9h80ra1